Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferations

被引:179
作者
Langerak, AW [1 ]
van den Beemd, R [1 ]
Wolvers-Tettero, ILM [1 ]
Boor, PPC [1 ]
van Lochem, EG [1 ]
Hooijkaas, H [1 ]
van Dongen, JJM [1 ]
机构
[1] Erasmus Univ, Univ Rotterdam Hosp, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.1182/blood.V98.1.165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clonality assessment through Southern blot (SB) analysis of TCRB genes or polymerase chain reaction (PCR) analysis of TCRG genes is important for diagnosing suspect mature T-cell proliferations. Clonality assessment through reverse transcription (RT)-PCR analysis of V beta -C beta transcripts and flow cytometry with a V beta antibody panel covering more than 65% of V beta domains was validated using 28 SE-defined clonal T-cell receptor (TCR)alpha beta (+) T-ALL samples and T-cell lines. Next, the diagnostic applicability of the V beta RT-PCR and flow cytometric clonality assays was studied in 47 mature T-cell proliferations. Clonal V beta -C beta RT-PCR products were detected in all 47 samples, whereas single VP domain usage was found in 31 (66%) of 47 patients. The suspect leukemic cell populations in the other 16 patients showed a complete lack of V beta monoclonal antibody reactivity that was confirmed by molecular data showing the usage of V beta gene segments not covered by the applied V beta monoclonal antibodies. Nevertheless, this could be considered indirect evidence for the "clonal" character of these cells. Remarkably, RT-PCR revealed an oligoclonal pattern in addition to dominant V beta -CP products and single V beta domain expression in many T-LGL proliferations, providing further evidence for the hypothesis raised earlier that T-LGL derive from polyclonal and oligoclonal proliferations of antigen-activated cytotoxic T cells. It is concluded that molecular V beta analysis serves to assess clonality in suspect T-cell proliferations. However, the faster and cheaper V beta antibody studies can be used as a powerful screening method for the detection of single V beta domain expression, followed by molecular studies in patients with more than 20% single V beta domain expression or large suspect T-cell populations (more than 50%-60%) without V beta reactivity, (C) 2001 by The American Society of Hematology.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 46 条
[11]  
Friedman TM, 1998, J IMMUNOL, V161, P41
[12]  
GASCHET J, 1995, BONE MARROW TRANSPL, V16, P427
[13]   TCR-V GENE USAGE IN AUTOIMMUNITY [J].
GOLD, DP .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (06) :907-912
[14]  
GORSKI J, 1994, J IMMUNOL, V152, P5109
[15]  
GRUNEWALD J, 1992, CLIN EXP IMMUNOL, V89, P279
[16]  
GRUNEWALD J, 1996, IMMUNOLOGIST, V4, P99
[17]  
Hodges E, 1998, CLIN EXP IMMUNOL, V112, P363
[18]   TCR gene polymorphisms and autoimmune disease [J].
Kay, RA .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1996, 23 (02) :161-177
[19]  
KNEBA M, 1994, BLOOD, V84, P574
[20]   Dysregulation of CD95/CD95 ligand apoptotic pathway in CD3+ large granular lymphocyte leukemia [J].
Lamy, T ;
Liu, JH ;
Landowski, TH ;
Dalton, WS ;
Loughran, TP .
BLOOD, 1998, 92 (12) :4771-4777